Position in INCY
as of Mar 31, 2026
· filed Apr 17, 2026
Position Value
$294,783
-$14,465 QoQ
Shares Held
3,132
+0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AdvisorNet Financial, Inc holds $2,790,551 across 42 Biotechnology names. INCY ranks #3 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,864 | $1,278,890 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
8,003 | $380,702 | |
| 3 | INCY |
Incyte Corp
This page
|
3,132 | $294,783 | |
| 4 | TECH |
BIO-TECHNE Corp
|
4,055 | $211,914 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
135 | $104,306 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
2,565 | $82,105 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
1,620 | $53,816 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
171 | $44,172 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $294,783 | 3,132 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $309,248 | 3,131 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $256,211 | 3,021 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $205,730 | 3,021 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $182,376 | 3,012 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $216,534 | 3,135 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $209,470 | 3,169 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $213,624 | 3,524 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $229,133 | 4,022 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $251,913 | 4,012 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $229,693 | 3,976 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $248,875 | 3,998 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $287,923 | 3,984 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $333,006 | 4,146 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $274,690 | 4,122 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $312,768 | 4,117 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $325,780 | 4,102 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $296,315 | 4,037 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $277,664 | 4,037 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $329,116 | 3,912 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $313,458 | 3,857 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $335,481 | 3,857 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $346,127 | 3,857 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $401,012 | 3,857 | Shares | Sole | 2020-08-26 | |
| 2020-03-31 | $282,448 | 3,857 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||